COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks

BACKGROUND: As precision medicine gradually played an inaccessible role in cancer treatment, there was an urgent need to explore biomarkers or signatures for predicting cancer prognosis. Currently, little was known about the associations between COLGALT1 and kidney renal clear cell carcinoma (KIRC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiwei, Yu, Yang, Wang, Yi, Zhu, Bingye, Han, Bangmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287979/
https://www.ncbi.nlm.nih.gov/pubmed/35842702
http://dx.doi.org/10.1186/s40001-022-00745-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287979/
https://www.ncbi.nlm.nih.gov/pubmed/35842702
http://dx.doi.org/10.1186/s40001-022-00745-5

Ejemplares similares